“Why are you bringing all these cancer patients into the hospital and putting us all at risk?” asked one of my non-IO colleagues. An undiagnosed COVID patient brought in that day for an extended procedure resulted in losing six staff to a week-long quarantine.
Treating cancer patients during the CO
As we all struggle to provide optimal care for our patients during these unprecedented times, it is clear that the pandemic has affected us all in different ways: with differing timing, magnitude, resource constraints, and local policies.
Given these circumstances, it is difficult to develop broadl
In a major breakthrough, ECOG-ACRIN has nominated interventional oncologists to the Neuroendocrine and Colorectal Task Forces of the GI Steering Committee of the NCI National Clinical Trials Network (NCTN).
A collaboration among interventional oncologists pooling outcomes of 155 patients with neuroendocrine tumor liver metastases treated at seven cancer centers across the United States has won the CVIR Award for most highly cited article at the 2018 CIRSE Annual Meeting in Lisbon, Portugal.
Optimal patient care is no longer the province of solitary specialists; rather it is provided by multidisciplinary care teams. This has lead to the genesis of diseased-centered subspecialty societies